The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report


The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes:

  •       Market Overview -- What you need to know about MDR and more
  •       Major M&A Deals by Sector
  •       For Ophthalmology, Orthopedic & Spine, and Woundcare - Key Developments and Deals
  •       Key Stats on Top M&A Deals in Q3 2022
  •       Performance of Leading Healthcare Companies
  •       Analysis of More Than 60 Q3 M&A Transactions

Click here to download the Report.